American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) . Washington, DC: APA.
Banov, M. D., Zarate, C. A., Tohen, M., et al (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. Journal of Clinical Psychiatry, 55, 295–300.
Barnes, T. R. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672–676.
Bench, C. J., Lammertsma, A. A., Grasby, P. M., et al (1996) The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88, 059-01) determined by positron emission tomography. Psychopharmacology, 124, 141–147.
Bowden, C. L., Calabrese, J. R., Sachs, G., et al (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry, 60, 392–400.
Cuesta, M. J., Peralta, V. & Zarzuela, A. (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophrenia Research, 48, 17–28.
First, M. B., Spitzer, R. L., Gibbon, M., et al (1997) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Patient Version. Washington, DC: American Psychiatric Press.
Goldstein, J. M., Cohen, L. S., Horton, N. J., et al (2002) Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Research, 110, 27–37.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology (Revised). Bethesda, MD: US Department of Health, Education and Welfare.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.
Judd, L. L., Akiskal, H. S., Schettler, P. J., et al (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530–537.
Kane, J. M. & Smith, J. M. (1982) Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry, 39, 473–481.
Kinon, B. J., Basson, B. R., Gilmore, J. A., et al (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. Journal of Clinical Psychiatry, 62, 92–100.
Morgan, H. F. (1972) The incidence of depressive symptoms during recovery from hypomania. British Journal of Psychiatry, 120, 537–539.
Schooler, N. R. & Kane, J. M. (1982) Research diagnoses for tardive dyskinesia [letter]. Archives of General Psychiatry, 39, 486–487.
Simpson, G. M. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, S11–S19.
Strakowski, S. M., Keck, P. E., McElroy, S. L., et al (1998) Twelve-month outcome after a first hospitalization for affective psychosis. Archives of General Psychiatry, 55, 49–55.
Tohen, M., Stoll, A. L., Strakowski, S. M., et al (1992) The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophrenia Bulletin, 18, 273–282.
Tohen, M., Chengappa, K. N., Suppes, T., et al (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry, 59, 62–69.
Tohen, M., Zarate, C. A., Hennen, J., et al (2003) The McLean–Harvard First-Episode Mania Study: prediction of recovery and first recurrence. American Journal of Psychiatry, 160, 2099–2107.
Vieta, E., Goikolea, J. M., Corbella, B., et al (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Journal of Clinical Psychiatry, 62, 818–825.
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429–435.
Zarate, C. A., Rothschild, A., Fletcher, K. E., et al (2000) Clinical predictors of acute response with quetiapine in psychotic mood disorders. Journal of Clinical Psychiatry, 61, 185–189.